SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11571702
Source:
http://linkedlifedata.com/resource/pubmed/id/11571702
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008059
,
umls-concept:C0026769
,
umls-concept:C0254119
pubmed:issue
4
pubmed:dateCreated
2001-9-25
pubmed:abstractText
Multiple sclerosis is a chronic demyelinating disease rare in children. Currently marketed disease modifying therapies are limited to adults.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8101187
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0174-304X
pubmed:author
pubmed-author:FreyR ERE
,
pubmed-author:GoodkinDD
,
pubmed-author:HerbertJJ
,
pubmed-author:HietpasJJ
,
pubmed-author:LacyJJ
,
pubmed-author:MillerCC
,
pubmed-author:RenselMM
,
pubmed-author:SchwidSS
,
pubmed-author:StewartTT
,
pubmed-author:WaubantEE
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
211-3
pubmed:dateRevised
2008-1-16
pubmed:meshHeading
pubmed-meshheading:11571702-Adjuvants, Immunologic
,
pubmed-meshheading:11571702-Adolescent
,
pubmed-meshheading:11571702-Child
,
pubmed-meshheading:11571702-Dose-Response Relationship, Drug
,
pubmed-meshheading:11571702-Female
,
pubmed-meshheading:11571702-Humans
,
pubmed-meshheading:11571702-Interferon-beta
,
pubmed-meshheading:11571702-Male
,
pubmed-meshheading:11571702-Multiple Sclerosis, Relapsing-Remitting
,
pubmed-meshheading:11571702-Patient Compliance
,
pubmed-meshheading:11571702-Retrospective Studies
,
pubmed-meshheading:11571702-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Interferon beta-1a in children with multiple sclerosis is well tolerated.
pubmed:affiliation
UCSF/Mt Zion Multiple Sclerosis Center, San Francisco, CA, USA. emmanuelle.waubant@psl.ap-hop-paris.fr
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't
,
Evaluation Studies